- Current report filing (8-K)
19 Agosto 2009 - 3:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
August 18, 2009
Date of Report (Date of Earliest Event Reported)
HOSPIRA, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other
Jurisdiction of Incorporation)
1-31946
|
|
20-0504497
|
(Commission File
Number)
|
|
(I.R.S. Employer
Identification No.)
|
275 N. Field Drive
Lake Forest, Illinois 60045
(Address Of Principal Executive Offices, including Zip Code)
Registrants Telephone Number, Including Area Code:
(224) 212-2000
Not Applicable
(Former Name or
Former Address, If Changed Since Last Report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01
Other
Events
In a form 8-K filed on August 14,
2009, Hospira, Inc. (Company) reported that, pursuant to legal
proceedings not related to the safety of our product, the FDA suspended the
ANDA approval for our oxaliplatin products. On August 18, 2009, the
court order initiating the ANDA suspension was dissolved. On August 19,
2009, the Company received notice that the previously suspended ANDA has been
reinstated by the FDA. The Company has resumed shipments of the
product. Legal proceedings related to this product are ongoing.
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
HOSPIRA,
INC.
|
|
|
|
|
Dated:
August 19, 2009
|
/s/
Brian J. Smith
|
|
By:
|
Brian
J. Smith
|
|
Its:
|
Senior
Vice President, General Counsel and Secretary
|
3
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024